QuidelOrtho (QDEL) EBITDA (2021 - 2024)

QuidelOrtho has disclosed EBITDA across 4 years of filings, most recently posting -$1.8 billion for Q1 2024.

• In Q1 2024, EBITDA fell 1865.06% year-over-year to -$1.8 billion; the TTM figure through Mar 2024 stood at -$1.7 billion (down 412.17% YoY), while the FY2024 annual figure was -$2.0 billion, down 1509.71% from the prior year.
• EBITDA came in at -$1.8 billion for Q1 2024 at QuidelOrtho, down from $40.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $620.7 million in Q2 2022 to a low of -$1.8 billion in Q1 2024.
• Average EBITDA over 4 years is -$22.0 million, with a median of $56.8 million recorded in 2022.
• Year-over-year, EBITDA soared 242.06% in 2022 and sank 1865.06% in 2024.
• Over 4 years, EBITDA stood at $281.8 million in 2021, then tumbled by 79.84% to $56.8 million in 2022, then dropped by 29.4% to $40.1 million in 2023, then slumped by 4484.04% to -$1.8 billion in 2024.
• Per Business Quant data, the three most recent EBITDA figures were -$1.8 billion in Q1 2024, $40.1 million in Q4 2023, and $26.3 million in Q4 2023.